Minerva Surgical is dedicated to technological innovations for the modern treatment of Abnormal Uterine Bleeding (AUB). In 2020 Minerva affirmed this commitment with the acquisition of the Symphion System for Operative Hysteroscopy, the Genesys HTA Endometrial Ablation System, and Resectr for office-based tissue removal. Minerva revolutionized the treatment of AUB in 2015 with the introduction of its
endometrial ablation system, Minerva ES.